GLABF
Price
$0.48
Change
-$0.04 (-7.69%)
Updated
Jul 24 closing price
Capitalization
36.59M
VYGR
Price
$3.24
Change
-$0.07 (-2.11%)
Updated
Jul 25 closing price
Capitalization
179.29M
5 days until earnings call
Interact to see
Advertisement

GLABF vs VYGR

Header iconGLABF vs VYGR Comparison
Open Charts GLABF vs VYGRBanner chart's image
GEMINA LABORATORIES
Price$0.48
Change-$0.04 (-7.69%)
Volume$10K
Capitalization36.59M
Voyager Therapeutics
Price$3.24
Change-$0.07 (-2.11%)
Volume$581.88K
Capitalization179.29M
GLABF vs VYGR Comparison Chart in %
Loading...
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLABF vs. VYGR commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLABF is a Hold and VYGR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (GLABF: $0.48 vs. VYGR: $3.24)
Brand notoriety: GLABF and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLABF: 254% vs. VYGR: 81%
Market capitalization -- GLABF: $36.59M vs. VYGR: $179.29M
GLABF [@Biotechnology] is valued at $36.59M. VYGR’s [@Biotechnology] market capitalization is $179.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLABF’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • GLABF’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than GLABF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLABF’s TA Score shows that 3 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • GLABF’s TA Score: 3 bullish, 3 bearish.
  • VYGR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GLABF is a better buy in the short-term than VYGR.

Price Growth

GLABF (@Biotechnology) experienced а -8.33% price change this week, while VYGR (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($179M) has a higher market cap than GLABF($36.6M). GLABF YTD gains are higher at: -12.999 vs. VYGR (-42.857). GLABF has higher annual earnings (EBITDA): -3.73M vs. VYGR (-97.25M). VYGR has more cash in the bank: 236M vs. GLABF (15K). GLABF has less debt than VYGR: GLABF (244K) vs VYGR (42M). VYGR has higher revenues than GLABF: VYGR (67M) vs GLABF (10.9K).
GLABFVYGRGLABF / VYGR
Capitalization36.6M179M20%
EBITDA-3.73M-97.25M4%
Gain YTD-12.999-42.85730%
P/E RatioN/A6.00-
Revenue10.9K67M0%
Total Cash15K236M0%
Total Debt244K42M1%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLABFVYGR
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
49%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
50%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
50%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
38%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVBIY45.305.80
+14.68%
Innovent Biologics Inc.
OTGLY17.480.04
+0.23%
CD Projekt SA
RANKF1.57N/A
N/A
Rank Group (THE) p.l.c.
RMTG0.07N/A
-3.11%
Regenerative Medical Technology Group Inc.
SMDRF0.56-0.03
-4.28%
Sierra Madre Gold and Silver Ltd.

GLABF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLABF has been loosely correlated with ELVAF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GLABF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLABF
1D Price
Change %
GLABF100%
N/A
ELVAF - GLABF
36%
Loosely correlated
N/A
TNFA - GLABF
29%
Poorly correlated
-11.52%
IDRSF - GLABF
23%
Poorly correlated
N/A
VYGR - GLABF
22%
Poorly correlated
-2.11%
ENTO - GLABF
8%
Poorly correlated
-1.05%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-2.11%
RGNX - VYGR
51%
Loosely correlated
-1.86%
KYMR - VYGR
50%
Loosely correlated
-0.13%
XNCR - VYGR
49%
Loosely correlated
N/A
TRDA - VYGR
49%
Loosely correlated
+2.35%
IMNM - VYGR
47%
Loosely correlated
-3.29%
More